Market access is no longer just a final hurdle—it’s a strategic imperative that shapes how therapies reach the patients who need them most. If you’ve ever wondered what it really takes to bring a treatment from the lab to the lives it’s meant to change, this article is for you.
In Pharmaphorum’s latest Deep Dive, “Demystifying Market Access: Inside the Complex Journey from Lab to Patient,” industry experts including Greg Skalicky, Katya Svodoba and Brett Olson from EVERSANA unpack the evolving dynamics of access strategy, stakeholder engagement, and the critical role of data in accelerating impact.
Whether you’re in commercial strategy, patient services, or communications, this piece offers valuable insights into the forces shaping our industry’s future.
Read the full article here.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…